Sangita Reddy: How Does Our Own Healthcare Journey in India Look Through the Same Lens?
Sangita Reddy, Joint Managing Director at Apollo Hospitals Group, shared a post on LinkedIn:
“Listening to Dr. Ezekiel Emanuel in conversation with Dr. Tom Frieden, I found myself asking:
How does our own healthcare journey in India look through the same lens?
The conversation focused on the challenges facing the U.S. healthcare system.
What struck me was not which country has the ‘better’ system, but how differently two very different nations are addressing many of the same fundamental questions.
The U.S. has extraordinary medical and scientific capabilities, yet continues to grapple with affordability, access, prevention and equity.
Our challenge is different: more than 1.4 billion people, extraordinary diversity, vast geographic and economic differences, finite resources, and the simultaneous burden of communicable and chronic disease.
And necessity has driven us to innovate differently.
We are bringing together financial protection through Ayushman Bharat, primary care through Ayushman Arogya Mandirs, and digital health through ABDM and ABHA, alongside world-class clinical care and a pharmaceutical and vaccine ecosystem capable of delivering quality at extraordinary scale and affordability.
These are not isolated achievements.
They reflect a different way of designing healthcare.
Using scale to create efficiency.
Technology to extend access. Frugal innovation to deliver more with less. Public-private partnership to expand capacity. And inclusion by design.
We still have unfinished business. Out-of-pocket expenditure remains too high. Access and quality are uneven. Workforce and infrastructure require sustained investment.
But acknowledging these challenges should not diminish the magnitude of the transformation.
We have been solving healthcare in one of the world’s most complex real-world environments. And that experience increasingly matters beyond our borders.
As countries everywhere confront ageing, chronic disease, rising costs, workforce shortages and unequal access, perhaps the answer is not simply to spend more. It is to design better.
Our next opportunity is even greater: to move from treating illness to anticipating it; from reactive care to prevention; from healthcare delivery to health preservation. AI, digital health, genomics and connected care can help make that transition possible.
For much of the past century, healthcare innovation largely flowed from the developed world to India.
I believe that direction is changing.We are increasingly developing solutions shaped by our realities designed for affordability, diversity, inclusion and reach.
And those lessons can travel.
Our greatest contribution to global health will not be claiming that we have solved every problem. It will be demonstrating what is possible and sharing what we learn as we continue the journey.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience